Real-world safety of systemic psoriasis therapies: the critical role of registry data
British Journal of Dermatology · 18.08.2026 · 195 (3) · e45-e46
DOI: 10.1093/bjd/ljag250 ↗Kurz gefasst
Kommentar in der Zeitschrift British Journal of Dermatology, online erschienen am 17.06.2026. Verfasst von Brigitte Stephan. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Brigitte Stephan; Antipsoriatic medications and their safety: why seeking for registry data exploration, British Journal of Dermatology, , ljag250, https:/
Autor:innen und Institutionen
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
ORCID-Profile: Brigitte Stephan
Zitieren
APA
Stephan, B. (2026). Real-world safety of systemic psoriasis therapies: the critical role of registry data. British Journal of Dermatology, 195(3), e45-e46. https://doi.org/10.1093/bjd/ljag250
Vancouver
Stephan B. Real-world safety of systemic psoriasis therapies: the critical role of registry data. British Journal of Dermatology. 2026;195(3):e45-e46. doi:10.1093/bjd/ljag250
BibTeX
@article{Stephan2026,
author = {Stephan, Brigitte},
title = {Real-world safety of systemic psoriasis therapies: the critical role of registry data},
journal = {British Journal of Dermatology},
year = {2026},
volume = {195},
number = {3},
pages = {e45--e46},
doi = {10.1093/bjd/ljag250}
}
EUVIMED